Updated:
Synthesis Capital (Australia)
Synthesis Capital is an early-stage venture capital firm headquartered in Melbourne, Australia. The firm specializes in investing in healthcare startups...
Synthesis Capital (Australia)
Synthesis Capital is an early-stage venture capital firm headquartered in Melbourne, Australia. The firm specializes in investing in healthcare startups located across the Asia-Pacific region. Its investment scope covers companies ranging from the pre-seed stage through Series A+. By providing staged capital, Synthesis Capital aims to support the ongoing growth of its portfolio companies. In addition to financial backing, the firm offers company-building support to help founders scale their operations. Synthesis Capital's primary sector focus is on health and medtech innovation.
General information
Firm type
Venture Capital
Location
Country
Australia
City
Melbourne
Corporate office
Melbourne, Australia
Sector focus
Frequently asked questions
What stages of investment does Synthesis Capital target?
Synthesis Capital invests in healthcare startups from the pre-seed stage through Series A+.
What sectors does Synthesis Capital focus on?
The firm is focused on health and medtech innovation across the Asia-Pacific region.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: